Abstract
Takotsubo cardiomyopathy was first reported in Japan in 1990. Recently, an increasing number of case reports and reviews of takotsubo cardiomyopathy has been published worldwide, including atypical cases with inverted takotsubo cardiomyopathy or incidental coronary artery disease. To date, there has been no guideline for worldwide consensus on takotsubo cardiomyopathy diagnostic criteria and treatment. The onset mechanism of takotsubo cardiomyopathy is still controversial, although, catecholamine cardiotoxicity is considered to be the most likely cause. Here, we summarize the current case reports and reviews in regard to diagnosis, cardiac biomarkers, electrocardiogram, cardiac imaging, mechanism, treatment and prognosis in order to establish a deeper understanding of this syndrome.
Keywords: Ampulla cardiomyopathy, broken heart syndrome, catecholamine cardiotoxicity, mimicking acute myocardial infarction, neurogenic stunned myocardium, stress cardiomyopathy, transient left ventricular apical ballooning syndrome, Takotsubo cardiomyopathy, ampulla car-diomyopathy, ventriculography, subarachnoid hemorrhage, Pheochromocytoma, ventriculogram, scintigraphy, myonecrosis, electrocardiograms, computed tomography, 123-I-meta-iodobenzyl-guanidine, single-photon emission computed tomography, iodine-123-beta-methyl-p-iodophenyl pentadecanoic acid, iatrogenic, bevacizumab, paraneoplastic phe-nomena, intraaortic balloon pump-ing (IABP), prednisolone, methylprednisolone, pulmonary edema, Brain natriuretic peptide, ST-elevation myocardial infarction, Magnetic resonance imaging, Tallium-201, 18F-fluoro-deoxy-glucose, Intraventricular pressure gradient, Fragile X mental retardation-1
Current Pharmaceutical Design
Title: Takotsubo Cardiomyopathy
Volume: 16 Issue: 26
Author(s): Keisuke Kida, Yoshihiro J. Akashi, Giovanni Fazio and Salvatore Novo
Affiliation:
Keywords: Ampulla cardiomyopathy, broken heart syndrome, catecholamine cardiotoxicity, mimicking acute myocardial infarction, neurogenic stunned myocardium, stress cardiomyopathy, transient left ventricular apical ballooning syndrome, Takotsubo cardiomyopathy, ampulla car-diomyopathy, ventriculography, subarachnoid hemorrhage, Pheochromocytoma, ventriculogram, scintigraphy, myonecrosis, electrocardiograms, computed tomography, 123-I-meta-iodobenzyl-guanidine, single-photon emission computed tomography, iodine-123-beta-methyl-p-iodophenyl pentadecanoic acid, iatrogenic, bevacizumab, paraneoplastic phe-nomena, intraaortic balloon pump-ing (IABP), prednisolone, methylprednisolone, pulmonary edema, Brain natriuretic peptide, ST-elevation myocardial infarction, Magnetic resonance imaging, Tallium-201, 18F-fluoro-deoxy-glucose, Intraventricular pressure gradient, Fragile X mental retardation-1
Abstract: Takotsubo cardiomyopathy was first reported in Japan in 1990. Recently, an increasing number of case reports and reviews of takotsubo cardiomyopathy has been published worldwide, including atypical cases with inverted takotsubo cardiomyopathy or incidental coronary artery disease. To date, there has been no guideline for worldwide consensus on takotsubo cardiomyopathy diagnostic criteria and treatment. The onset mechanism of takotsubo cardiomyopathy is still controversial, although, catecholamine cardiotoxicity is considered to be the most likely cause. Here, we summarize the current case reports and reviews in regard to diagnosis, cardiac biomarkers, electrocardiogram, cardiac imaging, mechanism, treatment and prognosis in order to establish a deeper understanding of this syndrome.
Export Options
About this article
Cite this article as:
Kida Keisuke, J. Akashi Yoshihiro, Fazio Giovanni and Novo Salvatore, Takotsubo Cardiomyopathy, Current Pharmaceutical Design 2010; 16 (26) . https://dx.doi.org/10.2174/138161210793176509
DOI https://dx.doi.org/10.2174/138161210793176509 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Pharmacologic Management of Pediatric Heart Failure in Congenital Heart Disease
Current Vascular Pharmacology Drugs Targeting the Canonical NF-κB Pathway to Treat Viral and Autoimmune Myocarditis
Current Pharmaceutical Design Risk Prediction Models and Scores in Hypertrophic Cardiomyopathy
Current Pharmaceutical Design The Metabolic Approach in Patients with Heart Failure: Effects on Left Ventricle Remodeling
Current Pharmaceutical Design High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease
Current Pharmaceutical Design The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets
Current Pharmaceutical Design The Two fACEs of the Tissue Renin-Angiotensin Systems: Implication in Cardiovascular Diseases
Current Pharmaceutical Design Bis(2-aminoimidazolines) and Bisguanidines: Synthetic Approaches, Antiparasitic Activity and DNA Binding Properties
Current Medicinal Chemistry The Evolving Therapy of Rheumatic Diseases, The Future is Now
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Biomarkers Associated with Atrial Fibrosis and Remodeling
Current Medicinal Chemistry Measurement of the Endogenous Adenosine Concentration in Humans In Vivo: Methodological Considerations
Current Drug Metabolism HER-2 Signaling and Inhibition in Breast Cancer
Current Cancer Drug Targets Membrane Rafts in the Respiratory System
Current Respiratory Medicine Reviews Respiratory Syncytial Virus (RSV) Prevention and Treatment: Past, Present, and Future
Cardiovascular & Hematological Agents in Medicinal Chemistry The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs
Current Vascular Pharmacology Sarcolemmal K<sub>ATP</sub> Channel Modulators and Cardiac Arrhythmias
Current Medicinal Chemistry Target Peptide Recognition by S100P Protein and Role of Central Linker Region and Dimer Interface
Protein & Peptide Letters Evolution and Analysis of Heterogeneity in the Clinical Expression of Aortic Diseases Similar to Marfan’s Syndrome: Challenge and Art in Clinical Diagnosis
Current Rheumatology Reviews Molecular Diagnosis and Treatment of Multiple Endocrine Neoplasia Type 2B in Ethnic Han Chinese
Endocrine, Metabolic & Immune Disorders - Drug Targets Cardiac (myo)fibroblast: Novel Strategies for its Targeting Following Myocardial Infarction
Current Pharmaceutical Design